CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 129 filers reported holding CHEMOCENTRYX INC in Q4 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,052,000 | +35.5% | 117,152 | -35.0% | 0.02% | +37.5% |
Q2 2022 | $4,467,000 | -84.6% | 180,285 | -68.1% | 0.02% | -78.4% |
Q1 2021 | $28,997,000 | -5.7% | 565,911 | +13.9% | 0.07% | -8.6% |
Q4 2020 | $30,760,000 | +3.1% | 496,764 | -8.7% | 0.08% | -14.7% |
Q3 2020 | $29,833,000 | +0.4% | 544,396 | +5.4% | 0.10% | -8.7% |
Q2 2020 | $29,725,000 | +8.0% | 516,591 | -24.6% | 0.10% | -14.8% |
Q1 2020 | $27,534,000 | +44.7% | 685,269 | +42.5% | 0.12% | +93.7% |
Q4 2019 | $19,022,000 | – | 480,953 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |